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SUMMARY Within the larger Seattle Heart Watch arteriography registry, surgically treated patients nonrandomly selected for direct myocardial revascularization were matched to medically treated patients such that each of the 287 pairs was identical in seven variables (ejection fraction, ventricular arrhythmia on resting electrocardiogram, age, heart murmur, stenosis of left main coronary artery >50%, number of vessels with stenosis >70%, and use of diuretics) previously demonstrated to be independently predictive of survival. Actuarial survival analyses based on cardiovascular deaths (average follow-up 3.5 years) indicate improved survival for the entire surgical matched pair cohort (p = 0.008) and for the surgically treated subgroup with twovessel disease (p = 0.0002) when compared to the medical cohort. These results were confirmed by examination of the entire arteriography registry (n = 1524) in which these seven variables were known, using Cox's model for survival analysis. This multivariate, statistical technique indicated that the surgical mode of therapy was significantly predictive of improved survival in surgically treated patients for the entire registry (p = 0.008) and for the subgroup with two-vessel disease (p = 0.0005).
WHILE DIRECT MYOCARDIAL REVASCU-LARIZATION often provides symptomatic relief for patients with chronic angina, the effect of surgery on survival is controversial." 2 We have reported on survival analyses of nonrandomized medically and surgically treated patients who had been classified and compared according to ejection fraction and number of stenotic (.70%) vessels. 3 Although we noted better survival in surgically treated patients with normal or moderately abnormal ejection fraction and two-vessel disease, differences remained in survival-related variables between the two cohorts which may have accounted for some of the differences in survival. In this report we will detail further survival analyses and attempt to correct for the differences between the two cohorts caused by the nonrandom selection for surgery. The results suggest that surgical therapy provides improved survival over medical therapy in patients with two-vessel disease.
Methods
We have used two approaches in our analyses: a univariate, matched pair technique and a complex, multivariate analysis, the Cox's regression model for survival data.4
In the first report of the current two-part series we identified the seven variables that were most predictive of survival, using univariate and multivariate analyses on coronary disease patients from the angiography registry of the Seattle Heart Watch. The patients were carefully characterized by clinical, resting and exercise electrocardiographic, hemodynamic, coronary arteriographic, and quantitative angiographic variables. These seven variables, in order of decreasing statistical significance, were: ejection fraction, ventricular arrhythmia on resting ECG, age, heart murmur on auscultation, stenosis of left main coronary artery (.50%), number of stenotic (.70%) vessels, and use of diuretics. A computer program was developed to match one medically treated patient with one surgically treated patient such that each pair was identical according to the discontinuous variables (ventricular arrhythmia, heart murmur, left main stenosis >50%, number of vessels with stenosis >70%, and diuretic use). For the continuous variables, each pair was within a similar, specified range (age <29, 30-34, ... , 65-69, .70 years; ejection fraction <30%, 31-50%, >51%). Since there were 1145 surgical patients and 379 medical patients with these seven variables known, occasionally more than one surgical patient was available for matching to a medical patient (rarely vice versa). If this were the case, the patient completing the matched pair was chosen randomly. The matching process produced 287 matched pairs. Actuarial survival curves were constructed using cardiovascular deaths, including operative mortality for the surgically treated patients. Curves were constructed for the entire matched pair cohort and also for subgroups with one-, two-and three-vessel disease (stenosis .70%). Noncardiovascular deaths were treated as patients lost to followup. The mean follow-up is 3.5 years. The significance of the difference between survival curves was tested with the Mantel-Haenzel-Cox statistic. 5 To examine for differences between the medical and surgical cohorts of the matched pairs, the 46 variables examined in the preceding paper were compared between the two cohorts. The t test was used to test for significant differences between continuous variables, and 2 X K contingency table analyses with chisquared statistics were used to test for differences in distributions of discrete variables.
Cox's Regression Analysis
Cox's regression analysis with a proportional hazards model was used to test whether the type of therapy (medical or surgical) was predictive of survival when entered into the analysis with the seven previously identified variables. Cox's regression analysis, an analog of multiple linear regression analysis applied to censored survival data, corrects for differences in survival between medical and surgical cohorts produced by these seven variables and tests for the effect of surgery. It also has the advantage of using data on all patients for whom these seven variables were known (1524), in contrast to the matched-pair analysis which was limited to 574 patients (287 pairs). Figure 1 shows the survival curves for all 287 medically treated and 287 surgically treated patients included in the matched pair analysis, demonstrating improved survival (p = 0.008) in the surgically treated patients. In the surgical cohort the estimated survival at 2 years is 0.96 ± 0.01 (SEM) and 0.96 ± 0.01 at 4 years. For the medical cohort, the equivalent estimated survivals were 0.92 ± 0.02 and 0.86 ± 0.02, respectively. Th, operative mortality (30-day mortality) was 2.1% (six of 287). Figure 2 shows the survival curves for the subgroup of 140 pairs with single-vessel disease, illustrating no 100 - FIGURE 3 . A ctuarial survival curves basei deaths for the 97 matched pairs with two-vess (>70%) showing a highly significant (p = 0.0A ment in survival in the surgically treated pat significant difference (p = 0.251) in si medical or surgical therapy. The 2ani timated survivals for surgically treated p 0.97 ± 0.01 and 0.97 + 0.01, respectivel treated patients had corresponding estima of 0.96 + 0.02 and 0.93 ± 0.02, respei operative mortality was 0.7% (one of 14 Figure 3 shows the survival curves for with two-vessel disease, indicating a mark (p = 0.0002) in survival between medica gically treated patients. The 2-and 4-ye, survivals for surgically treated pal 0.98 ± 0.02 and 0.98 ± 0.02, respectivel) survivals for medically treated pal 0.88 ± 0.03 and 0.76 + 0.05, respec operative mortality was 0% (0 of 97). Figure 4 shows the survival curves for of patients with three-vessel disease. statistically significant difference (p = 0.4 >(II)I the survival of the medically and surgically treated patients with three-vessel disease. However, the surgical mortality was relatively high (10%; five of 50). _______(64 -The curves have crossed at about 2 years; the surgical cohort exhibited slightly better (not statistically significant) survival after 2 years of follow-up. Because the Veterans Administration Cooperative Study' observed no significant difference in survival between medical and surgical therapy once patients with left main coronary artery lesions had been separated out, we repeated the survival analyses excluding patients with left main coronary artery stenosis >50%. There were only six pairs with left main coronary artery lesions. Exclusion of these six pairs of patients produced results virtually identical to d on cardiac those shown in figures 1-4. ,el obstucadion Even though these two cohorts had been matched ,el obstruction by all seven variables independently predictive of sur-902) improve-vival, we examined the comparability of these two ients.
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Significantly more surgically treated patients were classified as New York Heart Association functional the 50 pairs class III and IV than medically treated patients There is no (p = 0.01). Table 1 shows the results of Cox's proportional hazards regression analysis testing for the effect of mode of therapy (medical vs surgical) on survival while correcting for the seven variables predictive of survival. These multivariate analyses of the entire patient population in which these seven variables were known confirm the results of the survival curves of the matched pair cohort shown in figures 1-4: surgical therapy is significantly related to improved survival for the group as a whole and for patients with twovessel disease, but not for patients with single-or three-vessel disease.
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To determine whether direct myocardial revascularization improves survival in patients with ' on cardiac coronary disease, we compared the survival of nonran-!1 obstruction domly allocated, surgically treated patients to that of erence in sur-medically treated patients who have been matched by rted patients.
the seven variables most significantly related to sur- vival. The improved survival with surgical therapy in the group as a whole and in patients with two-vessel disease was confirmed by Cox's regression analysis on the entire patient population for whom these seven variables were known.
Methodologic Standards
Gifford and Feinstein, in a paper assessing previously published studies on the use of anticoagulants in acute myocardial infarction, established eight methodologic standards which they regarded as "scientific necessities for ensuring comparability of treated patients in a clinical investigation of therapy."6 These remain valid criteria for assessing therapeutic trials: statement of diagnostic criteria of disease under study, experimental trial, concurrent controls, random allocation, hospital coordination, stratified prognostic correlation, diagnostic criteria for endpoints, and double-blind technique.
Non-random Allocation
Of these eight criteria it is usually random allocation that causes the greatest concern when it is absent occasionally to the extent that some investigators refuse to accept results from any clinical trial in which subjects were not randomly allocated. Randomized trials of medically and surgically treated coronary disease patients generally allow the best comparison of survival, providing that adequate numbers of patients are randomized and that the spectrum of disease studied is sufficiently broad to allow meaningful extrapolation to clinical situations. However, it is becoming increasingly difficult to conduct randomized trials, particularly trials comparing a surgical therapy with a nonsurgical therapy. It is particularly difficult in the case of myocardial revascularization, where significant emotionalism prevails, and the evidence for better relief of symptoms by surgical therapy is strong.7 Therefore, it is vital to explore techniques which can extract useful information and allow valid conclusions from the comparison of patient populations that were allotted to medical or surgical therapy nonrandomly.
The selection of patients for surgical therapy of coronary disease usually picks patients with an intrinsically better prognosis than patients selected for medical therapy. In our previous report,2 we demonstrated that though we compared patients with similar extent of coronary disease and similar ejection fraction (two variables thought to be most predictive of survival based on data then available), surgically treated patients generally had more graftable vessels, fewer subjective contraction abnormalities on left ventricular angiogram, and smaller end-diastolic volumes.
It is our thesis that, if patients are sufficiently well characterized by the variables predictive of survival, selection differences can be taken into account by using special statistical techniques such as the matched pair technique or Cox's regression analysis.
First, variables predictive of survival must be identified. This was one of the purposes of this paper. Our patients are characterized by nearly all of the important variables (or equivalents thereof) previously reported8 to be predictive of survival in coronary disease patients, and as completely or more completely characterized than any preceding study comparing the survival of nonrandomized medically and surgically treated coronary disease patients.9-18 However, there are probably additional unmeasured or undescribed variables with prognostic significance. To alter our conclusions, such unmeasured variables would have to give independent prognostic information beyond (in a multivariate, statistical sense) that given by the 46 variables used in this study, and be distributed significantly and differently distributed between the medical and surgical cohorts. The differences in survival between medically and surgically treated patients with two-vessel disease are now great enough that such an unmeasured variable would have to be a powerful predictor of prognosis (probably more so than any of the seven used) and have a marked distribution difference between medically and surgically treated patients in order to invalidate surgical therapy as a cause of improved survival in this group. This is un-Abbreviations: n = number of patients in each group for whom all seven variables were known for Cox's regression analysis.
likely, but continued surveillance with validation of current trends will be important.
Other Methodologic Standards
This study fully meets four of the remaining seven methodologic criteria proposed by Gifford and Feinstein5 (statement of diagnostic criteria of disease under study, concurrent controls, stratified prognostic correlation, and criteria for end points), and meets two partially (experimental trial and hospital coordination). In regard to experimental trial, the data collection and follow-up were largely carried out prospectively, but this is not a trial in the sense that treatment was allocated solely for the purposes of the study. Considerable hospital coordination has been used, including uniform data forms, definitions, exercise tests, and central analysis of left ventricular angiograms. However, there was no coordination in terms of specifying primary mode of therapy (surgery) or adjunctive modes of therapy (e.g., propranolol, restriction of smoking, and diet). Surgical trials cannot be double-blind.
In addition to these eight methodologic criteria, we have proposed a ninth which is vital to analysis of nonrandomized surgical trials: the exclusion or censorship of early medical deaths.3 By definition, the surgical cohort has survived from time of catheterization to surgery (average 30 days). In all previous, nonrandomized analyses, patients who died before scheduled surgery were considered medically treated patients, thereby giving an unduly poor prognosis to the medical cohort. Because such patients are not easily identified retrospectively, we have excluded all deaths that occurred in the medical cohort within 30 days of catheterization. This is very conservative, since not all patients who died during this period were going to have surgery. There were 11 such early medical deaths among the 379 medically treated patients from whom the matched pairs were selected. Including these deaths in the analysis will amplify the differences in survival between medical and surgical cohorts.
Single-Vessel Disease
As in all studies to date, we observed no significant differences in survival between medically and surgically treated patients with single-vessel disease. However, average follow-up times have been short (3-5 years), and it may take more time for small differences in survival to become apparent. In this regard, our survival curves appear to be separating, so continued surveillance will be important.
Two-Vessel Disease
The improved survival with surgical therapy in patients with two-vessel disease was seen in both the subgroup with normal ejection fraction (.0.51; p = 0.01) and the subgroup with moderately reduced ejection fraction (0.31-0.50; p = 0.017). Only two matched pairs were in the subgroup with severe impairment of ejection fraction (<0.30), too few to draw deaths within 30 days after surgery in the 97 surgically treated patients. This is lower than the 3.3% (15 of 459) operative mortality for all operated patients with two-vessel disease in Seattle Heart Watch. Even with our average operative mortality of 3.3% for patients with two-vessel disease it is likely that there would still be a highly significant difference in survival, since the difference in survival between medically and surgically treated patients was 10% at 2 years and 22% at 4 years.
Three-Vessel Disease
The failure to demonstrate improved survival in the surgical cohort appears to be due to a high operative mortality (10%; five of 50) in a rather small subset of patients. However, the curves have crossed at about 2 years, with ongoing mortality in the medical cohort and remarkably few late deaths in the surgical cohort. Continued surveillance is particularly important in this subgroup to confirm the trend of reduced late mortality in the surgical cohort.
Comparisons With Other Studies
The conclusions of the VA Cooperative Study' and of the present report are quite different. We have included patients with left main coronary artery stenosis .50% (six pairs) in the present analysis, while they were separated out of the VA analysis. However, exclusion of these six pairs of patients results in virtually no change in the survival curves of the medicalsurgical comparisons. There is a small proportion of patients with significant left main coronary artery lesions (2.1 %; 6 of 287) because most of these patients had surgery, leaving few in the medical cohort available for matching by this variable.
The differences between the two studies in patients with two-vessel disease could be the result of either poor survival in Seattle Heart Watch medically treated patients or better survival in Seattle Heart Watch surgically treated patients compared to comparable groups of VA Cooperative Study patients. We classified patients in the matched pair analysis into normal and abnormal left ventricular function, following as closely as possible the criteria used in the VA Cooperative Study. We defined abnormal left ventricular function as any one of the following: ejection fraction <0.45, subjective contraction abnormality on left ventricular angiogram (our contraction grade = 3, 4, or 5), left ventricular end-diastolic volume >105 ml/m2, and left ventricular end-diastolic pressure > 14 mm Hg. These differ slightly from the VA study in that we defined an enlarged left ventricle quantitatively, while it was defined qualitatively in the VA study. Also, the VA study used 50% or more reduction in luminal diameter as a definition of significant disease, while we used 70%. Table 2 is a comparison of 2year survival between the two studies for comparable groups of patients. The standard error of survival probabilities was supplied by Dr. Marvin Murphy and co-workers. The largest difference occurs in surgically any meaningful conclusion. There were no operative left ventricular function where the Seattle Heart Watch patients appear to have better survival. The VA surgically treated patients with two-vessel disease and normal left ventricular function have a particularly poor 2-year survivallower, in fact, than either their surgically treated patients with threevessel disease and normal left ventricular function or their surgically treated patients with two-vessel disease and abnormal left ventricular function.
Therapeutic Implications
Our data should not be extrapolated to recommend revascularization for all patients with two-vessel disease regardless of symptoms. First, since 90% of our patients had angina (523 of 584), extrapolation to the asymptomatic patient with two-vessel disease is probably not appropriate. Second, patients over 65 years of age may be anticipated to have less potential for improvement in prognosis than patients in their forties or fifties. However, the younger, symptomatic patient with two-vessel disease who has graftable distal vessels and no marked impairment of left ventricular function (ejection fraction .0.30) should not be required to "fail" a prolonged trial of medical therapy before they are offered surgery, since the prognosis may be improved by surgery.
